Brooke Wilson
@drbrookewilson
Followers
402
Following
257
Media
7
Statuses
91
Medical Oncologist, global oncology, breast and GI cancer, health services researcher, statistics, PhD student, momx3
Joined May 2019
RT @nazik_hammad: Incredibly privileged to belong @csoncol with amazing colleagues @scottrberry @OphiraG @jrgralow &many .
0
4
0
RT @ManniMD1: The Q of whether dietary interventions help people with cancer is very imp. RCTs are the gold standard for evaluating interv….
pubmed.ncbi.nlm.nih.gov
Most RCTs of dietary interventions in cancer are small and measure nonclinical endpoints. Although only a small number of large RCTs have been conducted to date, these trials have not shown an...
0
38
0
RT @fabiomoraesmd: It has been an immense honor to contribute to this project. Working alongside a team of exceptionally talented individua….
0
6
0
RT @SullivanProf: Power, money & cancer medicines. A reality check.
ecancer.org
Cancer medicines: a private vice for public benefit? Richard Sullivan Institute of Cancer Policy, Centre for Cancer, Society & Public Health, King&r
0
26
0
RT @QueensUHealth: Cancer #research programs led by @drbrookewilson & Dr. Sebastien Talbot have received @cancersociety Emerging Scholar Re….
0
3
0
RT @shalsubra: In this cohort of Australian patients with advanced cancers, at least 20% had some expectation of cure from palliative syste….
0
8
0
RT @JournalCancer: Efficacy-effectiveness gaps between clinical trials and real-world populations are likely to extend well beyond gaps in….
acsjournals.onlinelibrary.wiley.com
Efficacy-effectiveness (EE) gaps are typically associated with survival outcomes. In this commentary, the authors review potential EE gaps in quality of life, toxicity, cost-effectiveness, and...
0
4
0
RT @csoncol: We are excited to announce an upcoming series of focus groups with members of the oncology community regarding their perceptio….
0
16
0
RT @JournalCancer: Efficacy-effectiveness gaps between clinical trials and real-world populations are likely to extend well beyond gaps in….
acsjournals.onlinelibrary.wiley.com
Efficacy-effectiveness (EE) gaps are typically associated with survival outcomes. In this commentary, the authors review potential EE gaps in quality of life, toxicity, cost-effectiveness, and...
0
6
0
RT @TheWonkologist: Survey of @ASCO members finds oncologists are REMARKABLY unconcerned about industry influence on cancer care. Y'all,….
0
17
0
RT @fabiomoraesmd: 🚨Radiotherapy resources in Brazil (RT2030): a comprehensive analysis and projections for 2030 🚨- The Lancet Oncology htt….
0
9
0
RT @JournalCancer: Older patients remain under-represented in clinical trials in oncology. However, there is no evidence of differential tr….
0
19
0
RT @QueensUHealth: A @QueensCRI double bill in @TheLancetOncol – @drbrookewilson is top author on a global study modelling treatment delive….
0
2
0
RT @oncology_bg: Amazing to have 3 important representations in @TheLancetOncol from @queenscce. 1. Dr Chris Booth is quoted in this news….
0
4
0
RT @SullivanProf: Read this report and ask yourself, in any world is this sustainable and affordable? How much of this is actually deliveri….
0
12
0
RT @QueensGlobalOnc: This is tomorrow! Looking forward to hearing from Dr. Ian Tannock. Be sure to register to receive the link.
0
5
0
RT @oncology_bg: We at @QueensGlobalOnc are privileged to have @Rubagumyaf spend a year with us for his fellowship. Tomorrow 8AM EST, he’ll….
0
3
0
RT @oncology_bg: A nice summary of the fantastic global oncology work happening at @QueensGlobalOnc under the leadership of @scottrberry. h….
healthsci.queensu.ca
This story is part of The Next 25, an ongoing series exploring how Queen's Health Sciences is reimagining health sciences education, research, and patient care.
0
5
0